NSC |
Compound |
Enrichment |
Correlation |
NSC 689133 |
1H,3H-Benzo[c]pyrrolo[3,4-a]carbazole-1,3-dione, 2,3a,3b,4,5,6,7,7a-octahydro-2-(4-methoxyphenyl)- 5-phenyl-9-(phenylmethoxy)- |
0.0163859626459254 |
0.16872665 |
NSC 692655 |
D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate |
0.0163859626459254 |
0.2373308 |
NSC 694493 |
9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-pyridinyl)- |
0.0163859626459254 |
0.2420764 |
NSC 727719 |
(-)-Leucascandrolide A |
0.0163859626459254 |
0.089570516 |
NSC 735001 |
Null |
0.0163859626459254 |
0.21310927 |
NSC 743562 |
Null |
0.0163859626459254 |
0.10329696 |
NSC 747287 |
Null |
0.0163859626459254 |
0.1990943 |
NSC 756158 |
GSK237700A |
0.0163859626459254 |
0.34247711 |
NSC 80466 |
1H-Naphth[2,3-d]imidazolium, 4,9-dihydro-1,2-dimethyl-3-(2-methylpropyl)-4,9-dioxo-, iodide |
0.0163859626459254 |
0.32868832 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0171490505199911 |
0.41965696 |